Indazolones as modulators of tnf signaling

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10160748
APP PUB NO 20180086737A1
SERIAL NO

15670708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE INC1 NORTH WAUKEGAN ROAD V377 AP-34-2 NORTH CHICAGO IL 60064

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Argiriadi, Maria Southborough, US 2 6
Breinlinger, Eric Charlton, US 4 8
Dietrich, Justin D Lindenhust, US 14 17
Friedman, Michael Brookline, US 127 2656
Ihle, David Worcester, US 6 11
LoSchiavo, Gloria Y Worcester, US 1 3
Morytko, Michael Framingham, US 18 69
Mullen, Kelly Charlton, US 4 8
Osuma, Augustine Lindenhurst, US 11 71
Wilson, Noel S Kenosha, US 18 147

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 25, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 25, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00